Saw palmetto is a lipid/sterol extract of the ripe berries of the fan palm Serenoa repens (syn. Sabal serrulata), native to the southeastern United States. The commercially relevant fraction is rich in free fatty acids and phytosterols. It is sold as a dietary supplement (capsules, softgels, tablets, liquid extracts, teas) and is not an FDA-approved drug.
Marketed aggressively as a top-selling "men's/prostate health" supplement for enlarged-prostate (BPH) urinary symptoms, hair loss, and testosterone/libido, on a plausible-sounding DHT-blocking story (weak 5-alpha-reductase inhibition, the same pathway as finasteride/dutasteride). Reality: that enzyme effect is weak and, per NIH LiverTox, demonstrated only in vitro, not in humans. When the flagship BPH claim was tested in the largest, best-designed NIH-funded trials, it failed — NCCIH concludes saw palmetto is "probably not helpful" for BPH urinary symptoms. As a supplement it is legally barred from claiming to treat, cure, or prevent any disease.
This is the use the evidence most clearly refutes. NCCIH: 'We know enough to conclude that saw palmetto is probably not helpful' for BPH urinary symptoms. The NIH-funded CAMUS RCT (Barry, JAMA 2011; 369 men, escalated to 3x the standard 320 mg/d over 72 weeks) found 0.79 points favoring PLACEBO and concluded increasing doses 'did not reduce lower urinary tract symptoms more than placebo.' A 2023 NCCIH review of 27 studies found saw palmetto alone 'provides little or no benefit,' with hexane-extracted products no better. This is strong evidence of no clinically meaningful benefit, not merely absent evidence.
Human evidence is thin and low quality: small, short trials, often industry-run. A 2020 systematic review (PubMed 33313047) of 7 studies reported some positive signals (e.g., ~27% haircount improvement) but explicitly stated 'robust high-quality data are lacking.' NCCIH: the evidence is 'too limited to allow conclusions to be reached.' Do not expect finasteride/minoxidil-level results.
No good evidence of benefit. Because it is marketed as anti-androgen/anti-DHT, some users report the opposite — decreased sex drive; NCCIH consumer materials note reported effects including tender breasts and decline in sexual desire. The 'libido booster' framing is unsupported and may be directionally backwards.
A 2022 review of five studies (cited by NCCIH) found no significant benefit for chronic prostatitis/chronic pelvic pain syndrome.
No demonstrated role in preventing or treating prostate cancer; it is neither a screening tool nor a therapy. One narrow, useful note (a safety observation, not a benefit): unlike finasteride, saw palmetto does not appear to lower PSA readings even at higher doses (NCCIH, CAMUS), so it is less likely to mask a PSA result.
Most clinical trials used 320 mg/day of the lipid/sterol extract (once daily, or 160 mg twice daily), typically standardized to roughly 80-90% fatty acids/sterols. CAMUS tested up to 960 mg/day (3x) and still found no benefit — more was not better. This is not an FDA-regulated or endorsed dose; it is descriptive of what was studied. Because supplements are not verified for potency before sale, actual bottle content can vary widely from the label — choose a third-party-tested product.
Generally well tolerated; used safely in studies for up to 3 years with mild, infrequent effects: digestive upset, diarrhea, headache, dizziness, and some reports of tender breasts and decreased libido (NCCIH). CRITICAL WARNING — rare idiosyncratic liver injury: NIH LiverTox documents rare, unpredictable (not dose-related) cases of clinically apparent acute hepatotoxicity attributed to Serenoa repens after other causes were excluded; case reports of acute pancreatitis also exist (MSD Manual). Stop and seek care for yellowing skin/eyes, dark urine, right-upper-abdominal pain, nausea, or unusual fatigue. A theoretical bleeding risk has been reported (one case of surgical hemorrhage, possibly linked to a contaminated blended product). AVOID in pregnancy, breastfeeding, or if trying to conceive — NCCIH says it may be unsafe due to potential hormonal (anti-androgen) effects; safety data in women and children are essentially absent (nearly all research is in men). Interactions are not firmly established but data are insufficient to declare it interaction-free: use caution with anticoagulants/blood thinners (e.g., warfarin) given theoretical bleeding/liver concerns, and it may reduce the effectiveness of estrogen-containing medicines (oral contraceptives, HRT). Stop at least ~2 weeks before scheduled surgery and disclose all supplement use to your clinician, pharmacist, and anesthesiologist.
For its single most popular use — enlarged-prostate urinary symptoms — the best evidence says saw palmetto probably does NOT work: two large NIH-funded trials (STEP and CAMUS) and multiple reviews found it no better than placebo, even at triple the usual dose. For hair loss, libido/testosterone, prostatitis, and 'prostate health' broadly, evidence is weak-to-insufficient — nothing that justifies choosing it over proven options. It is usually mild and safe, with the main real risks being rare idiosyncratic liver injury, a theoretical bleeding risk, and clear avoidance in pregnancy. If you have bothersome urinary symptoms or hair loss, see a clinician for a real diagnosis and evidence-based treatment (e.g., alpha-blockers, 5-alpha-reductase inhibitors, finasteride/minoxidil) rather than relying on saw palmetto; if you still try it, buy a third-party-tested product, keep your doctor informed, and never use it to delay a prostate evaluation.
General information, not medical advice. Dietary supplements are not FDA-approved to treat, cure, or prevent any disease, and quality/purity vary by brand. Talk to your clinician or pharmacist before starting one — especially if you’re pregnant, breastfeeding, or take other medicines.